Robert F. Kennedy Jr.’s HHS nomination moves to a full Senate vote; Donald Trump’s tariff war sparks China-related concerns for biopharma; Pfizer, Merck and more announce Q4 and 2024 earnings; and the ...
Japan's epigenetics market is evolving rapidly, with a strong emphasis on AI-driven research and personalized medicine, addressing complex diseases through innovative therapeutic approaches.New Delhi, ...
The lack of awareness about rare diseases like prurigo nodularis and available treatment options is anticipated to impede market growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback